NCT06108232
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Neoplasms by Histologic Type
Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.
30,111 public trials
6,473 recruiting studies
Neoplasms by Histologic Type trial results
NCT07516093
- Conditions
- B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +19 more
- Locations
-
- Central Georgia Cancer Care Macon, Georgia, United States
- Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
- Hematology Oncology of Indiana Indianapolis, Indiana, United States
- SCRI Oncology Partners Nashville, Tennessee, United States
NCT07177079
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- University of Iowa Health Care Iowa City, Iowa, United States
Recruiting
Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)
NCT07478991
- Conditions
- Acute Myeloid Leukemia, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Complejo Hospitalario Universitario de A Coruña Santiago de Compostela, A Coruña, Spain
- ICO Hospitalet- Hospital Duran i Reynals Hospitalet Del Llobregat, Barcelona, Spain
- Hospital Mútua de Terrassa Terrassa, Barcelona, Spain
- Complejo Hospitalario de Jaén Jaén, Jaen, Spain
NCT05489783
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Glioma, +15 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) Commack, New York, United States
Recruiting
Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial
NCT07605416
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
Recruiting
Elranatamab in R/R Multiple Myeloma
NCT06138275
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT06828822
- Conditions
- Congenital Nevus, Mental Disorders, Naevi, +6 more
- Locations
-
- Grasse Hospital Nice, Alpes-Maritimes, France
- Nice University Hospital and Lenval Hospital Nice, Alpes-Maritimes, France
- Marseille University Hospital Marseille, Bouches-du-Rhône, France
- Dijon University Hospital Dijon, Côte-d'Or, France
NCT05896839
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Basal Cell, +34 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Keck Medicine of USC Koreatown Los Angeles, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
NCT07077161
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- LUMC Leiden, South Holland, Netherlands